drugset
drugset / Trial / NCT06755541

Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

NCT06755541 ↗

Phase 3 Recruiting 150 enrolled Xijing Hospital of Digestive Diseases
NaSingle-groupOpen-labelTreatment

Summary

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Fenofibrate in Combination with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis (PBC)

Timeline

Start
2024-01-30
Primary completion
2035-12
Completion
2035-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fenofibrate Small molecule 200 mg —
Background Ursodeoxycholic Acid Small molecule — —

Indications

primary biliary cholangitis